Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.

Jin L, Sturgis EM, Zhang Y, Huang Z, Song X, Li C, Wei Q, Li G.

Mol Cancer. 2013 Jul 19;12:80. doi: 10.1186/1476-4598-12-80.

2.

A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.

Zhang Y, Sturgis EM, Sun Y, Sun C, Wei Q, Huang Z, Li G.

Eur J Cancer. 2015 Jul;51(11):1415-23. doi: 10.1016/j.ejca.2015.04.016. Epub 2015 May 14.

3.

MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers.

Song X, Sturgis EM, Liu J, Jin L, Wang Z, Zhang C, Wei Q, Li G.

PLoS One. 2013;8(2):e56622. doi: 10.1371/journal.pone.0056622. Epub 2013 Feb 15.

4.

Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma.

Chen X, Sturgis EM, Lei D, Dahlstrom K, Wei Q, Li G.

Cancer Res. 2010 Sep 15;70(18):7199-208. doi: 10.1158/0008-5472.CAN-09-4733. Epub 2010 Aug 24.

5.

p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.

Ji X, Neumann AS, Sturgis EM, Adler-Storthz K, Dahlstrom KR, Schiller JT, Wei Q, Li G.

Carcinogenesis. 2008 Apr;29(4):875-9. doi: 10.1093/carcin/bgn039. Epub 2008 Feb 6.

PMID:
18258602
6.

A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.

Yuan Y, Sturgis EM, Zhu L, Lu M, Li Y, Wei Q, Li G.

Mol Carcinog. 2017 Mar;56(3):1100-1106. doi: 10.1002/mc.22576. Epub 2016 Oct 20.

PMID:
27677255
7.

Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.

Guan X, Sturgis EM, Lei D, Liu Z, Dahlstrom KR, Wei Q, Li G.

Clin Cancer Res. 2010 Mar 1;16(5):1416-22. doi: 10.1158/1078-0432.CCR-09-2877. Epub 2010 Feb 23.

8.

Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.

Jin L, Sturgis EM, Cao X, Song X, Salahuddin T, Wei Q, Li G.

FASEB J. 2013 Jun;27(6):2496-503. doi: 10.1096/fj.12-226803. Epub 2013 Feb 21.

9.

Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G.

Int J Cancer. 2014 Apr 15;134(8):1907-15. doi: 10.1002/ijc.28512. Epub 2013 Oct 24.

10.
11.

Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx.

Feng Y, Li Y, Zhang Y, Zheng H, Li G.

Oral Oncol. 2016 May;56:78-83. doi: 10.1016/j.oraloncology.2016.03.012. Epub 2016 Mar 28.

PMID:
27086490
12.

Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx.

Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, Wei Q, Li G.

Cancer Lett. 2013 Apr 28;330(2):233-40. doi: 10.1016/j.canlet.2012.11.048. Epub 2012 Dec 5.

13.

Combined p53-related genetic variants together with HPV infection increase oral cancer risk.

Wang Z, Sturgis EM, Zhang Y, Huang Z, Zhou Q, Wei Q, Li G.

Int J Cancer. 2012 Aug 1;131(3):E251-8. doi: 10.1002/ijc.27335. Epub 2011 Dec 2.

14.

Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck.

Zhou Z, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G.

Mol Carcinog. 2012 Oct;51 Suppl 1:E54-64. doi: 10.1002/mc.21838. Epub 2011 Nov 15.

15.

Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population.

Singh PK, Bogra J, Chandra G, Ahmad MK, Gupta R, Kumar V, Jain A, Ali Mahdi A.

Cancer Biomark. 2015;15(2):125-31. doi: 10.3233/CBM-140444.

PMID:
25519014
16.

Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity.

Li Y, Sturgis EM, Yuan Y, Lu M, Cao X, Wei Q, Li G.

Carcinogenesis. 2016 Sep 8. pii: bgw095. [Epub ahead of print]

PMID:
27609456
17.

Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck.

Zhou Z, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G.

BMC Cancer. 2012 May 1;12:159. doi: 10.1186/1471-2407-12-159.

18.

Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.

Zhu L, Sturgis EM, Zhang H, Lu Z, Tao Y, Wei Q, Li G.

Int J Cancer. 2017 Oct 1;141(7):1355-1364. doi: 10.1002/ijc.30849. Epub 2017 Jul 7.

PMID:
28646528
19.

E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.

Li Y, Sturgis EM, Zhu L, Cao X, Wei Q, Zhang H, Li G.

Mol Carcinog. 2017 Apr;56(4):1335-1343. doi: 10.1002/mc.22595. Epub 2017 Jan 2.

PMID:
27864908
20.

Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx.

Yu H, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G.

Cancer. 2012 Mar 15;118(6):1684-92. doi: 10.1002/cncr.26423. Epub 2011 Aug 5.

Supplemental Content

Support Center